Portal messaging is the only reliable channel
Journal of Translational Medicine, 14
Research suggests Ozempic may modestly reduce C-reactive protein (CRP), interleukin-6 (IL-6), and tumour necrosis factor-alpha (TNF-), though these effects are often secondary to weight loss and improved glycaemic control
noted that although gastrointestinal issues have been related to GLP-1 antagonist use, they consider a diagnosis of gastroparesis to be unusual. Hyposalivation Research has found that semaglutide can cause secondary xerostomia, otherwise known as dry mouth (19)
[1] Signs of significant dehydration include dizziness upon standing, dry mouth, decreased urination, and concentrated urine
Guaranteed Quality 99%+ HPLC-verified purity Proven Results Trusted by hundreds of researchers Tested Quality Third-party lab verified Trusted Source USA-based, priority shipping